文献速递甲状腺与颈部外科

散发性甲状腺髓样癌多灶性与低肿瘤分级相关且驱动突变及总生存无差异

Multifocality in sporadic medullary thyroid carcinoma is associated with low tumor grade and no difference in somatic driver mutations or overall survival when compared with unifocal tumors.
PubMed 文献 · Surgery · 2025-10-10

该回顾性队列研究纳入5个高容量中心的270例非胚系甲状腺髓样癌患者,比较多灶与单灶肿瘤的肿瘤分级、驱动突变及生存。结果显示多灶患者C细胞增生比例更高,但低分级比例、淋巴结阳性比、局部复发及总生存均无统计学差异,多灶性不与不良总生存相关。

要点

  • 散发性甲状腺髓样癌中多灶性常见,中位病灶大小0.60 cm。
  • 多灶与单灶肿瘤的低分级比例、驱动突变及淋巴结阳性比无差异。
  • 多灶性不增加局部复发风险,也不影响总生存。

核心结论

  • 散发性甲状腺髓样癌多灶性常见,亚厘米多灶灶多见。
  • 多灶性与单灶肿瘤在肿瘤分级、淋巴结负荷、总生存及体细胞驱动突变上无差异。
  • 多灶性不与不良总生存相关。

研究设计与样本

  • 回顾性队列分析,纳入5个高容量甲状腺髓样癌中心1986年1月1日至2018年1月1日患者。
  • 270例非胚系甲状腺髓样癌患者,207例(77%)单灶,63例(23%)多灶。
  • 分子分析采用RET胚系检测和/或靶向外显子测序(匹配正常DNA)。

主要发现

  • 多灶患者C细胞增生比例显著高于单灶(48% vs 9%,P < .001)。
  • 低分级比例单灶75% vs 多灶79%(P = .45)。
  • 多灶病灶中位大小0.60 cm(四分位距0.3-1.0 cm),74%含多个病灶。
  • 淋巴结阳性比多灶0.37(四分位距0-0.66)vs 单灶0.27(四分位距0-0.43),P = .23。
  • 局部复发(P = .25)和总生存(P = .31)无统计学差异。

临床怎么用

  • 对于散发性甲状腺髓样癌,多灶性本身不应视为不良预后因素。
  • 多灶性患者中C细胞增生更常见,需关注但不必过度解读为侵袭性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Total thyroidectomy for patients with sporadic medullary thyroid carcinoma is often recommended because of multifocality. The International Medullary Thyroid Carcinoma Grading System is established as a predictor of disease-specific outcomes. We aimed to study multifocality and its association with index tumor grade and somatic mutations. METHODS: A retrospective cohort analysis of 5 high-volume medullary thyroid carcinoma centers was performed between January 1, 1986, and January 1, 2018. Thyroidectomy specimens were evaluated for multifocality. Molecular profiling was assessed with RET germline testing and/or targeted exome sequencing of specimens with matched normal DNA. Outcomes evaluated were risk of local recurrence, distant recurrence, and survival within 15 years. RESULTS: Among 270 patients with nongermline medullary thyroid carcinoma, 207 (77%) were unifocal and 63 (23%) multifocal (P < .05). A similar proportion of patients were low-grade (unifocal: 75% vs multifocal: 79%; P = .45) although a significantly greater proportion of multifocal patients demonstrated C-cell hyperplasia (48% vs 9%; P < .001). Molecular profiling identified no differences among driver mutations. The median size of multifocal lesions was 0.60 cm (interquartile range: 0.3-1.0 cm) with 74% harboring multiple foci. The ratio of positive lymph nodes in dissected compartments was similar (multifocal: 0.37, interquartile range: 0-0.66 vs unifocal: 0.27, interquartile range: 0-0.43; P = .23). Local recurrence (P = .25) and overall survival (P = .31) were not statistically different between cohorts. CONCLUSION: Subcentimeter multifocality is common in sporadic medullary thyroid carcinoma. In this study cohort, no differences were observed in tumor grade, lymph node burden, overall survival, or somatic driver mutations compared with unifocal tumors. Multifocality in patients with sporadic medullary thyroid carcinoma is not associated with adverse overall survival.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Nigam A, Mederos MA, Aksoy YA, et al. Multifocality in sporadic medullary thyroid carcinoma is associated with low tumor grade and no difference in somatic driver mutations or overall survival when compared with unifocal tumors. Surgery. 2025. PMID: 41073156. doi:10.1016/j.surg.2025.109764

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。